Pediatric Dose Optimization for Seizures in EMS (Pedi-DOSE)
G
Gregory Faris
Primary Investigator
Overview
DID YOU KNOW?... Seizures are one of the most common reasons why people call 9-1-1 for children. Seizures that do not stop on their own can be life-threatening.
Researchers at Indiana University School of Medicine are looking for children to take part in a study to identify ways help improve processes to ensure that a commonly used medication to treat seizures (called Midazolam) is given in the right dose by paramedics to children during an emergency to help stop a seizure.
The goal of this study is to decrease the number of children arriving athe emergency department with an ongoing seizure while maintaining
patient safety.
Description
To learn more about PediDOSE, visit https://www.texaschildrens.org/research/area/neurology/pedidose-study
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
seizure
-
Age: Between 6 Months - 13 Years
-
Gender: All
Inclusion Criteria:
- Children ages 6 months to 13 years
- Transported by Indianapolis Emergency Medical Services (EMS) to IU Health Riley Hospital for Children for active seizure
Exclusion Criteria:
Updated on
03 May 2024.
Study ID: 12322, EMER-UTAH-PEDIDOSE
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
